2016
DOI: 10.1016/j.atherosclerosis.2016.06.029
|View full text |Cite
|
Sign up to set email alerts
|

LDL-C/apoB and HDL-C/apoA-1 ratios predict incident chronic kidney disease in a large apparently healthy cohort

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
17
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 30 publications
(18 citation statements)
references
References 41 publications
(57 reference statements)
1
17
0
Order By: Relevance
“…Although non-HDL-c/HDL-c is a well-studied risk factor for CVD [13-15], this study is one of the first reporting its association with kidney disease [26]. Our study is also one of the first to relate varying lipid parameters to kidney disease using the novel CKD-EPI equation, which is as accurate as the MDRD Study equation at GFR<60 ml/min/1.73 m 2 but is more accurate at higher GFRs [17].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Although non-HDL-c/HDL-c is a well-studied risk factor for CVD [13-15], this study is one of the first reporting its association with kidney disease [26]. Our study is also one of the first to relate varying lipid parameters to kidney disease using the novel CKD-EPI equation, which is as accurate as the MDRD Study equation at GFR<60 ml/min/1.73 m 2 but is more accurate at higher GFRs [17].…”
Section: Discussionmentioning
confidence: 99%
“…observed varying non-HDL-c concentrations at different stages of albuminuria in type 1 diabetes and found that non-HDL-c was predictive of progression to end-stage renal disease (ESRD). Bae et al [45]. showed that higher non-HDL-c/HDL-c, but not non-HDL-c, was associated with a higher risk of incident CKD in a large and apparently healthy cohort.…”
Section: Discussionmentioning
confidence: 99%
“…The increase of one standard deviation of TG level and TG/HDL-cholesterol ratio was correlated with an increased risk of developing CKD. Additionally, increases of HDL-cholesterol level, LDL-cholesterol/ApoB and HDL-cholesterol/ApoAI ratios seemed to be protective [30]. …”
Section: Uremic Lipoproteins Evidences Of Toxicitymentioning
confidence: 99%
“…Some scholars already proposed the hypothesis of the common mechanism of glomerular sclerosis and arteriosclerosis [20]. The serum cholesterol levels, including the increase of low-density lipoprotein (LDL) and the decrease of high-density lipoprotein (HDL), all participate in the progression of CKD, which involves mechanisms such as cholesterol transport in the body, inflammatory status mediated by lipid toxicity in dyslipidemia, and increased cardiovascular risks [21]. The 2013 KIDIGO blood lipid management guideline recommends using all blood lipid indicators for the assessment of abnormal blood lipid profile conditions in patients; in addition, appropriate treatment intervention should be performed according to age and the level of kidney function [22].…”
Section: Discussionmentioning
confidence: 99%